Price target
13.790.000.00%
The 7 analysts offering 1 year price forecasts for VERV have a max estimate of — and a min estimate of —.
Analyst rating
Based on 9 analysts giving stock ratings to VERV in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
VERV EPS for the last quarter is −0.35 USD despite the estimation of −0.64 USD. In the next quarter EPS is expected to reach −0.68 USD. Track more of Verve Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Verve Therapeutics, Inc. revenue is expected to reach 4.27 M USD. Check out Verve Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, VERV price target is 13.79 USD with a max estimate of 20.00 USD and a min estimate of 11.00 USD. Check if this forecast comes true in a year, meanwhile watch Verve Therapeutics, Inc. stock price chart and keep track of the current situation with VERV news and stock market news.
We've gathered opinions of 9 analysts rating VERV stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.